Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MHG - Exam 2 > Lecture 28-Clinical Molecular Genetics 1 and 2 > Flashcards

Lecture 28-Clinical Molecular Genetics 1 and 2 Flashcards

1
Q

What is the difference between a genome mutation and a chromosome mutation?

A
  • genome: whole chromosomes absent or present in excess (ex: downs)
  • chromosome: chromosomes translocated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the difference between a mutation, polymorphism and a rare variant?

A
  • mutation: permanent change in the nucleotide sequence that causes a disease
  • polymorphism: a change in the DNA that does not cause disease and is in >1% of the population
  • Rare variant: a change in the DNA sequence that does not cause diseases and is in <1%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When a change in DNA sequence is found it can be hard to tell whether this is a _____ or _____.

A
  • mutation

- rare variant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

compound heterozygote

A

a person with 2 mutant alleles on the same gene (ex: CF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is advanced maternal age and paternal age? Why is this age set for women?

A
  • 35 for both
  • this is the age in women because this is the age at which the risk for a chromosome abnormality equals the risk of miscarrying the child
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Haploinsufficiency

A

Youre making the functional, normal protein just not enough of it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dominant negative

A

when the mutant protein disrupts the function of the normal protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Of dominant negative, haploinsufficiency, gain of function and loss of function which of these are dominant disorders?

A
  • gain of function
  • haploinsufficiency
  • dominant negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Achondroplasia inheritance

A

AD, always from father

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the rate at which individuals develop new mutations?

A
  • 80%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Achondroplasia results from a mutation in what gene? What kind of mutation is it and what does this cause?

A
  • FGFR3

- its a gain of function mutation that keeps the receptor constitutively active limits skeletal growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can you test for achondroplasia?

A
  • 99% of people with achondroplasia have a G–>A transition that alters restriction enzyme sites. The other 1% has a G –> C transversion that also alters restriction sites
  • The G–>A digests with SfcI to give 109 and 55 bp segments
  • The G–>C digests with MspI to give bands of 107 and 57
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Are most people with dominant achondroplasia heterozygous or homozygous?

A
  • heterozygous because both of the parents would’ve had to have had the condition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is MR associated with achondroplasia?

A
  • no
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

semidominant trait

A

can distinguish between hetero and homozygous trait (homozygous is lethal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the most common fatal autosomal recessive disease in Caucasians?

A
  • CF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

(T/F) Different CF mutations are associated with different ethnic groups.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What chromosome is the CF gene on?

A
  • 7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How many mutations for CF have been described?

A

1800

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

∆F508

A

most common CF mutation–in frame

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

p.W1282X

A

most common CF mutation in Ashkenazi Jews

- nonsense mutation so RNA is either degraded or you make a truncated protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

3120+1G–>A

A

most common CF mutation in AAs

- splicing variant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

If you find one of these mutations does that automatically tell you that the patient has CF?

A
  • no, you would have to find RNA or the protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What facts do you need to make a DIAGNOSIS of CF?

A
  • clinical feature, family history or positive neonatal screening test
    AND
  • positive sweat Cl, 2 CFTR mutation or positive nasal transmembrane potential
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What type of mutation is R117H? Does having this mean the person will have CF? What do you have to look for?

A
  • missense
  • no, you have to look at intron 8 for T repeats of 5, 7, or 9. If the T repeat is 5, then your child will have CF, if its 7 or 9 your child will not have CF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

EXAM QUESTION: If you find a child with ∆F508 and R117H mutations, and also find that they have both 5T and 9T repeats, what does this tell you? What if there were 2 9T alleles?

A
  • the ∆F508 allele ALWAYS has a 9T associated with it, therefore the R117H allele has the 5T associated with it and therefore the child will have classic CF.
  • if there were 2, 9T alleles then this would not lead to disease because exon 9 wouldn’t be spliced out
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Why do the 5, 7 and 9T repeats affect the protein?

A
  • as the “tract” decreases, splicing efficiency decreases and results in skipping of exon 9. The 5T allele is in 90% of the transcripts that don’t have exon 9
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

∆F508, I148T and 3199del6 mutations are in linkage disequilibrium with ______ (i.e., they will not recombine without this, they are linked)

A

9T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Describe oligonucleotide ligation assay (OLA)

A
  • used to detect CF mutations
  • primers specific for mutant and normal alleles and a common primer or probe are mixed with test DNA.
  • This process is like PCR but the 2 pieces need to be ligated before the PCR reaction can occur and the ligation won’t occur if theres a mismatch between them. So either the mutant or the WT probe will bind to the test DNA, be ligated and will undergo a PCR reaction
  • fluorescent markers send a signal depending on which probe has bound and if there is a heterozygote then you get 2 peaks half the height of the homozygous peaks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the advantage to OLA?

A
  • its very quick
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

If someone has OLA done and they come back as a carrier for a mutation does this mean that they won’t have the disease?

A
  • no, they could still have a mutation in a CF gene that was not on the panel tested
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Aside from the obvious reasons (prenatal diagnosis, routine prenatal testing) why would you do a genetic test for CF?

A
  • to do a genotype-phenotype correlation: some mutations are associated with pancreatic sufficiency
  • helps you make a diagnosis when you can’t get sweat from a neonate or its indefinitive
  • male infertility workup: men with CF are sterile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Duchenne Muscular Dystrophy (DMS) inheritance

A
  • X linked
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

describe the DMS gene

A

HUGE: 2.4Mb, 79 exons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What accounts for the mutations that give rise to DMS? (3)

A
  • large deletions: ~60% of mutations (most detectable with PCR)
  • ~15% have premature stops (nonsense)
  • 5% are duplications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

(T/F) the larger the deletion, the worse the phenotype with DMS.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is associated with a less severe prognosis in DMS?

A
  • if the N and C termini are there and only part of the middle of the protein are missing because it will still maintain function. This is actually called Becker dystrophy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

in DMD what is the most common chromosomal alteration that causes this?

A

deletions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Hemizygote

A

a male iwth a single allele on an XL locus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the chance of a mother giving DMD (an XL disorder) when she has already had a child with it, and when you do NOT know if the mother is a carrier?

A
  • 2/3 chance she’s a carrier (because there’s a 1/3 chance the condition could’ve arisen by a new mutation since it’s XL) X 1/2 chance she passes on the gene X 1/2 chance she has a boy = 1/6
41
Q

What is the chance of a mother giving DMD (an XL disorder) when she has already had a child with it, and when you DO know the mother is a carrier?

A

1/2 chance of passing the gene X 1/2 chance she has a boy = 1/4

42
Q

What is MLPA?

A
  • A newer way to test for DMD (as opposed to PCR and densitometry) that is very similar to OLA
  • 2 probes (mutant vs. normal) with a “stuffer sequence” that does not bind the DNA can lay down on the test strand next to each other and only if theres a perfect match can ligation occur between them.
  • ligation, PCR (only if ligated)
  • the probes that annealed are amplified by PCR and the length of the strands (that are given by the stuffer sequences) are used to distinguish which one bound the parent strand and amplified during PCR
43
Q

How would you explain a mother who is not a carrier for DMD according to MLPA that has 2 children with DMD?

A
  • she could have germline mosaicism which is fairly common with DMD and in this case we wouldn’t see the mutations in the blood sample tested
44
Q

Where on genes to repeats occur?

A

ANYWHERE

45
Q

Freidrick’s Ataxia

A

only AR disease caused by repeats

46
Q

Polyglutamine/Polyalanine repeats

A
  • repeats only in exons
47
Q

Where are the Fragile X repeats located on a gene?

A

5’ UTR

48
Q

How do polyglutamine repeats compare in size to other types of repeats?

A
  • they’re smaller because they’re in an exon
49
Q

All known polyglutamine disorders are characterized by ______ that begins when? What will eventually happen?

A
  • neuronal dysfunction
  • midlife
  • results in severe neurodegeneration
50
Q

polyglutamine disorders are caused by ______.

A

toxic gain of function mechanism

51
Q

What kind of mutation are polyglutamine repeats? (i.e., loss of function, gain of function, haploinsufficient, or dominant negative)

A
  • dominant negative because they interfere with the WT protein function
52
Q

PolyQ repeats can be detected what 2 ways?

A
  • nucleic acid: trinucleotide repeat disorders, if you have 90 repeats you do SB
53
Q

2/3 of HD patients present with _____ while the other 1/3 present with _____

A
  • neurological disease

- psychiatric changes

54
Q

HD is from what repeat in what exon of what gene on what chromosome?

A
  • CAG
  • 1st exon
  • HTT gene
  • Ch4
55
Q

How many repeats do you need to be considered normal in HD? Affected?

A
  • normal: 10-26

- affected: 40+

56
Q

How could you differentiate each phase of HD? Early, Intermediate and Later?

A
  • Early: sublt changes in movements/coordination, often depressed/irritable mood)
  • Intermediate: chorea more noticeable, difficulty with voluntary activity and trouble swallowing and speaking
  • Later: total dependence, mute, incontinent
57
Q

What makes it possible for us to test presymptomatically with HD and why is it so important that we confirm our diagnoses?

A
  • we know the gene that’s affected

- we need to know we’re not dealing with something that looks like it

58
Q

HD inheritance?

A
  • AD, late onset usually after childbearing years
59
Q

Do we use SB or PCR for HD?

A

PCR

60
Q

Where do we get the prenatal child’s DNA for testing? Why do we have to be more sensitive about testing with this condition?

A
  • DNA from CVS and amniocytes

- you may have to test in a way that doesn’t reveal the genotype of an at-risk parent

61
Q

How do you test a child for HD without revealing the parent’s genotype?

A
  • linkage approach: essentially telling the parents whether or not the potential carrier passed on the allele from the non affected parent or the affected parent (which may or may not be the allele with the mutation)
62
Q

What are the 3 types of myotonic dystrophy?

A
  • mild
  • classical
  • congenital
63
Q

Myotonic dystrophy is suspected in adults with what symptoms?

A
  • muscle weakness
  • myotonia (sustained muscle contraction)
  • cataracts
64
Q

MD is suspected in neonates with what symptoms? (5)

A
  • hypotonia
  • facial muscle weakness
  • generalized weakness
  • club foot
  • respiratory insufficiency or failure
65
Q

What is the mutation in MD? (what gene on what chromosome, which repeat and in what region?)

A
  • DMPK
  • chromosome 19
  • CTG repeats
  • 3’ UTR
66
Q

What is the normal number of repeats in someone with MD?

A
  • > 50
67
Q

In MD, how does the length of the repeat correlate to the age of onset?

A

inverse correlation

68
Q

What is unique about the transference of MD between generations?

A
  • anticipation: when we either see an earlier age of onset as the mutation passes between generations or more severe phenotype because repeats expand as their passed on
69
Q

Infants with MD almost always inherit the expanded allele from ______

A

their mother

70
Q

If a woman has >300 repeats for MD what is the chance her child will be affected congenitally?

A

60%

71
Q

If the woman with >300 repeats for MD wanted to test her child, would you use PCR or SB?

A
  • SB: there would be 1000s of repeats!
72
Q

Why are there generally smears on SBs for MD patient samples?

A
  • the DNA is mitotically unstable so the amount of DNA in each cell varies slightly between cells
73
Q

Where do you get the DNA from the neonate for testing for MD?

A
  • CVS or amniocytes
74
Q

Given that the amount of repeats is inversely related to the time of onset, can we use the amount of repeats to predict when the onset of the disease will be?

A
  • no, but if there are >1000 repeats the child is more likely to have congenital MD
75
Q

What is the prevalence of PWS and AS?

A
  • PWS: 1/10-20,000

- AS: 1/20,000

76
Q

Can imprinting patterns vary between tissues?

A
  • yes, imprinting patters can change in the brain
77
Q

What are 2 big clues that imprinting is going on in a disease?

A
  • UPD is associated with abnormal development

- Consistent parental origin of the mutant allele in inherited disorder

78
Q

The “imprinted allele” refers to which allele?

A
  • the allele that’s silenced
79
Q

Explain how gene expression changes between imprinted genes, non-imprinted genes in deletions of chromosome parts (ex: PWS).

A
  • when you have one strand of DNA of a certain region, the imprinted genes will not be expressed so you don’t have enough of these
  • the non imprinted version of genes that are imprinted will have enough product because usually their partner on the homologous chromosome is silenced anyways
  • genes that don’t have imprinting probably have haploinsufficiency and this is why PWS patients usually have light hair and skin compared to their families, a gene for pigmentation is usually lost in these deletions
80
Q

What is a good tool to check for deletions particularly in PWS and AS?

A
  • FISH probes
81
Q

heterodisomy

- what does it result in?

A
  • M1 nondisjunction: results in 1 maternal and 1 paternal copy of the same chromosome in 1 gamete
82
Q

isodisomy

- what does it result in?

A
  • M2 nondisjunction: results in 2 paternal or 2 maternal copies of a chromosome in one gamete
83
Q

trisomy rescue

A
  • the fetus is initially trisomic but one chromosome is lost. Usually the trisomy is originally caused by the mother because nondisjunction events are more common in women
84
Q

monosomy rescue

A

fetus is initially monosomic but the chromosome is duplicated resulting in complete isodisomy

85
Q

Gamete complementation

A
  • one game is disomic and the other is nullisomic resulting in a zygote that has the right number of those chromosomes
  • this is more rare because there would have to be a nondisjunction event in both the mom and dad for this to occur
86
Q

How does UPD differ from a deletion in one of the 2 homologous chromosomes that are imprinted? How does this differ from a methylation defect?

A
  • you still have none of the genes that are normally imprinted
  • you have double the genes that are the non-imprinted form of imprinted genes although this doesn’t really affect the person
  • correct amount of non-imprinted genes
  • this does NOT differ from a methylation defect other than that in a methylation defect the genes are turned off because they look like a male/female chromosome (ex: receiving our mother’s paternal allele from our her)
87
Q

In both PWS and AS most of the time the disease is caused by what chromosomal change?

A
  • deletion
88
Q

Considering the distribution of causes between PWS and AS, they generally break down to the same causes in similar proportions except for what 2 things?

A
  • in AS 11% are from mutations in UBE3A
  • in AS 10% have normal molecular and cyto

NOTE: in the rest the next biggest cause of disease after deletions is UPD, then methylation defects, then translocations

89
Q

How can you check the cause of PWS or AS?

A
  • methylation analysis: 96% of the C’s in the critical region for these disorders are methylated in the maternal allele and none in the paternal
90
Q

UBE3As functions are normally seen where?

A

in the brain

91
Q

What are the 2 ways to do methylation analysis?

A
  • SB with HPAII that recognizes (and will not cut) at methylated GC sites
  • PCR after bisulfite treatment: changes unmethylated Cs –> Us. 2 primers are made (1 with C, 1 with U) and one common primer, run on gel
92
Q

What is the advantage to using PCR and bisulfite for methylation analysis?

A

requires less DNA and is quicker

93
Q

Of all the potential causes for PWS and AS, what causes should you think of if you see cousins with PWS and AS?

A
  • methylation defects

- chromosomal rearrangements

94
Q

What is OI inheritance?

A

AD

95
Q

Collagen is composed from what end to what end? What does this mean in terms of OI patients?

A
  • C terminus to N terminus

- mutations in the C terminus will be more detrimental

96
Q

Type I OI

A
  • null allele, less severe because you still have half functional collagen
97
Q

How do mutations in alpha1 collagen present (molecularly)?

A
  • mutations in the Gly

- mutant peptide messes up the normal collagen formation

98
Q

Type II OI

A
  • lethal
99
Q

How do mutations in alpha2 collagen present (molecularly)?

A
  • still get some normal and some abnormal collagen but this results in the more severe forms of Type II-IV (not type 1 since type 1 is the alpha 1 null)

MHG - Exam 2 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions